Evidence map›Paper›PMID 40274815›Full record

ArticleSchizophrenia (Heidelberg, Germany)2025

Heterogeneity of morphometric similarity networks in health and schizophrenia.

Joost Janssen, Ana Guil Gallego, Covadonga Martínez Díaz-Caneja, Noemi Gonzalez Lois, Niels Janssen, Javier González-Peñas, Pedro Macias Gordaliza, Elizabeth Buimer, Neeltje van Haren, Celso Arango and 3 more

Abstract read
In one paragraph

Article in Schizophrenia (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Structural similarity networks reveal brain vulnerability in dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  9. Structural MRI of brain similarity networks.Nature reviews. Neuroscience · 2025
    Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Joost Janssen *Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. joost.janssen76@gmail.com.ORCID http://orcid.org/0000-0001-7613-2067
Ana Guil Gallego *Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Covadonga Martínez Díaz-CanejaDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.ORCID http://orcid.org/0000-0001-8538-3175
Noemi Gonzalez LoisDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Niels JanssenDepartment of Psychology, Universidad de la Laguna, Tenerife, Spain.
Javier González-PeñasDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.ORCID http://orcid.org/0000-0002-3850-3012
Pedro Macias GordalizaCIBM Center for Biomedical Imaging, Lausanne, Switzerland.ORCID http://orcid.org/0000-0001-5305-3104
Elizabeth BuimerDepartment of Psychiatry, UMCU Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Neeltje van HarenDepartment of Psychiatry, UMCU Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Celso ArangoDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.ORCID http://orcid.org/0000-0003-3382-4754
René KahnDepartment of Psychiatry, UMCU Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0001-5909-8004
Hilleke E Hulshoff PolDepartment of Psychiatry, UMCU Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Hugo G SchnackDepartment of Psychiatry, UMCU Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.

Funding

ProNET: Psychosis-Risk Outcomes NetworkU01MH124639 · NIMH · YALE UNIVERSITY · PI CARRIE E BEARDEN, JOHN M KANE · 2020 to 2026
$81.2M
Randomized controlled trial of enhanced coordinated specialty care (CSC 2.0)P50MH115846 · NIMH · MCLEAN HOSPITAL · PI Dost Ongur · 2019 to 2026
$16.9M
The impact of social isolation on aging health in schizophreniaR01MH128971 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ABRAHAM REICHENBERG, Eva Velthorst · 2022 to 2026
$3.2M
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PI22/01621NIMH NIH HHS P50 MH115846NIMH NIH HHS R01 MH128971NIMH NIH HHS U01 MH124639
6 · The paper itself

Abstract

Reduced structural network connectivity is proposed as a biomarker for chronic schizophrenia. This study assessed regional morphometric similarity as an indicator of cortical inter-regional connectivity, employing longitudinal normative modeling to evaluate whether decreases are consistent across individuals with schizophrenia. Normative models were trained and validated using data from healthy controls (n = 4310). Individual deviations from these norms were measured at baseline and follow-up, and categorized as infra-normal, normal, or supra-normal. Additionally, we assessed the change over time in the total number of infra- or supra-normal regions for each individual. At baseline, patients exhibited reduced morphometric similarity within the default mode network compared to healthy controls. The proportion of patients with infra- or supra-normal values in any region at both baseline and follow-up was low (<6%) and similar to that of healthy controls. Mean intra-group changes in the number of infra- or supra-normal regions over time were minimal (<1) for both the schizophrenia and control groups, with no significant differences observed between them. Normative modeling with multiple timepoints enables the identification of patients with significant static decreases and dynamic changes of morphometric similarity over time and provides further insight into the pervasiveness of morphometric similarity abnormalities across individuals with chronic schizophrenia.

Identifiers

PMID40274815
PMCPMC12022303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.